高屈曲型假体置换治疗膝关节骨关节炎的随访研究
摘要
目的:
回顾总结高屈曲型假体置换治疗膝关节骨关节炎的临床疗效。
方法:
对南京医科大学第一附属医院关节外科自2005年1月至2007年12月之间,因膝关节骨关节炎采用高屈曲型假体(Nexgen- LPS- FLEX)施行的初次膝关节置换病例进行随访,共随访182例(258膝)。对术前和随访时患者的膝关节HSS评分、功能评分和疼痛评分,膝关节活动度,膝关节X线片,患者满意度以及出现的各种并发症等进行总结和分析,并对髌骨置换与否的临床效果进行比较。随访结果使用SPSS17.0统计软件包进行统计学分析。
结果:
实际随访到170例(237膝),随访率为93.41%。平均随访52.12月(36～60月)。膝关节HSS评分从术前平均40.28分(16～78分)增加到末次随访时的85.31分(69～98分)(P<0.05),优良率为88.82%。膝关节功能和疼痛评分分别由术前的8.6分( 0～19分)和13.6分( 5～23分)增加到17.6分(14～22分)和25.3分(18～30分)(P<0.05)。术前膝关节最大屈曲度平均为98.2°(10°～112.5°),末次随访时为130.8°(105.5°～138°) (P<0.05)。膝关节活动度也有明显改善。81.18%的患者对治疗效果满意。术后有28例(35膝)(16.43%)遗留不同程度的膝前痛。10例(13膝)(5.88%)残留≥5°的屈曲畸形。2例(2膝)(1.18%)术后发生下肢深静脉血栓,其中1例继发肺栓塞。2例(2膝)(1.18%)发生迟发性感染。2例(2膝)(1.18%)发生胫骨假体无菌性松动。1例假体周围出现无症状非进展性透亮线。其余膝关节假体位置及力线良好,股骨、胫骨以及髌骨假体周围无松动。
结论:
高屈曲型假体置换术治疗膝关节骨关节炎总体疗效满意,能提高患者的生活质量,改善关节功能,有效缓解疼痛。对晚期膝关节骨关节炎患者来说。膝关节置换术是一个较好的选择。
Objective:
To analyse and summarize the clinical results of total knee arthroplasty (TKA) on knee osteoarthritis(OA) retrospectively.
Methods:
182 patients (258 knees) with OA accepted primary total knee arthroplasty (TKA) with Nexgen-LPS-FLEX prosthesis between January 2005 and December 2007 from the First Affiliated Hospital of Nanjing Medical University were followed-up. The scores of knee HSS, pain and function, range of motion (ROM), post-operative x-rays of the knees, patients’satisfaction rate and the complications were evaluated. And the results of patellar retention or resurfacing were compared. The data were analyzed with SPSS 17.0 software.
Results:
Out of 182 patients (258 knees), 170cases (237 knees) had been followed up for an average of 52.12 months(ranged, 36~60 months) with a visted rate of 93.41%. The scores of HSS, function and pain increased respectively from 40.28 points(ranged, 16～78 points), 8.6 points(ranged, 0-19 points) and 13.6 points(ranged, 5～23 points) preoperatively to 85.3 points(ranged, 69-98 points), 17.6 points(ranged, 14-22 points) and 25.3 points(ranged, 18-30 points) (P<0.05) at the final followed-up. The excellent and good rate of knee HSS scores was 88.82%. Maximum degree of flexion increased from 98.2degrees(ranged, 10～112.5 degrees) to 130.8degrees(ranged, 105.5～138 degrees) (P<0.05), and the range of motion(ROM) were improved significantly. Patients' satisfactory rate was 81.18%. There was anterior knee pain remained in 28cases (35 knees)(16.43%) after the surgeries. Flexion deformity of greater than or equal to 5°was occurred in 10cases(13knees)(5.89%) and the deep vein thrombosis(DVT) occurred in 2 cases(2 knees)(1.18%), delayed infection in 2 cases(2 knees)(1.18%) and aseptic loosening of tibial components in 2 cases(2 knees)(1.18%). The asymptomatic, unprogressive periprosthetic lucent line was found in the X-ray film in one case. The position of the components and the alignment of the lower extremity were good.
Conclusion:
Total knee arthroplasty(TKA) used in the treatment of patients with knee OA has a good effect as a whole, which can significantly improve the life quality and the function of knee joint, ease the pain effectively. TKA is a good chioce for the patients' with OA knees.
回顾总结高屈曲型假体置换治疗膝关节骨关节炎的临床疗效。
方法:
对南京医科大学第一附属医院关节外科自2005年1月至2007年12月之间,因膝关节骨关节炎采用高屈曲型假体(Nexgen- LPS- FLEX)施行的初次膝关节置换病例进行随访,共随访182例(258膝)。对术前和随访时患者的膝关节HSS评分、功能评分和疼痛评分,膝关节活动度,膝关节X线片,患者满意度以及出现的各种并发症等进行总结和分析,并对髌骨置换与否的临床效果进行比较。随访结果使用SPSS17.0统计软件包进行统计学分析。
结果:
实际随访到170例(237膝),随访率为93.41%。平均随访52.12月(36～60月)。膝关节HSS评分从术前平均40.28分(16～78分)增加到末次随访时的85.31分(69～98分)(P<0.05),优良率为88.82%。膝关节功能和疼痛评分分别由术前的8.6分( 0～19分)和13.6分( 5～23分)增加到17.6分(14～22分)和25.3分(18～30分)(P<0.05)。术前膝关节最大屈曲度平均为98.2°(10°～112.5°),末次随访时为130.8°(105.5°～138°) (P<0.05)。膝关节活动度也有明显改善。81.18%的患者对治疗效果满意。术后有28例(35膝)(16.43%)遗留不同程度的膝前痛。10例(13膝)(5.88%)残留≥5°的屈曲畸形。2例(2膝)(1.18%)术后发生下肢深静脉血栓,其中1例继发肺栓塞。2例(2膝)(1.18%)发生迟发性感染。2例(2膝)(1.18%)发生胫骨假体无菌性松动。1例假体周围出现无症状非进展性透亮线。其余膝关节假体位置及力线良好,股骨、胫骨以及髌骨假体周围无松动。
结论:
高屈曲型假体置换术治疗膝关节骨关节炎总体疗效满意,能提高患者的生活质量,改善关节功能,有效缓解疼痛。对晚期膝关节骨关节炎患者来说。膝关节置换术是一个较好的选择。
Objective:
To analyse and summarize the clinical results of total knee arthroplasty (TKA) on knee osteoarthritis(OA) retrospectively.
Methods:
182 patients (258 knees) with OA accepted primary total knee arthroplasty (TKA) with Nexgen-LPS-FLEX prosthesis between January 2005 and December 2007 from the First Affiliated Hospital of Nanjing Medical University were followed-up. The scores of knee HSS, pain and function, range of motion (ROM), post-operative x-rays of the knees, patients’satisfaction rate and the complications were evaluated. And the results of patellar retention or resurfacing were compared. The data were analyzed with SPSS 17.0 software.
Results:
Out of 182 patients (258 knees), 170cases (237 knees) had been followed up for an average of 52.12 months(ranged, 36~60 months) with a visted rate of 93.41%. The scores of HSS, function and pain increased respectively from 40.28 points(ranged, 16～78 points), 8.6 points(ranged, 0-19 points) and 13.6 points(ranged, 5～23 points) preoperatively to 85.3 points(ranged, 69-98 points), 17.6 points(ranged, 14-22 points) and 25.3 points(ranged, 18-30 points) (P<0.05) at the final followed-up. The excellent and good rate of knee HSS scores was 88.82%. Maximum degree of flexion increased from 98.2degrees(ranged, 10～112.5 degrees) to 130.8degrees(ranged, 105.5～138 degrees) (P<0.05), and the range of motion(ROM) were improved significantly. Patients' satisfactory rate was 81.18%. There was anterior knee pain remained in 28cases (35 knees)(16.43%) after the surgeries. Flexion deformity of greater than or equal to 5°was occurred in 10cases(13knees)(5.89%) and the deep vein thrombosis(DVT) occurred in 2 cases(2 knees)(1.18%), delayed infection in 2 cases(2 knees)(1.18%) and aseptic loosening of tibial components in 2 cases(2 knees)(1.18%). The asymptomatic, unprogressive periprosthetic lucent line was found in the X-ray film in one case. The position of the components and the alignment of the lower extremity were good.
Conclusion:
Total knee arthroplasty(TKA) used in the treatment of patients with knee OA has a good effect as a whole, which can significantly improve the life quality and the function of knee joint, ease the pain effectively. TKA is a good chioce for the patients' with OA knees.
引文
[1] American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum, 2000, 43(9):1905-1915.
[2] Pavone V, Boettner F, Fickert S, et al. Total condylar knee arthroplasty: a long- term followup. Clin Orthop Relat Res. 2001, 388(7): 18-25.
[3] Worland RL, Johnson GV, Alemparte J, et al. Ten to fourteen year survival and functional analysis of the AGC total knee replacement system. Knee, 2002, 9(2): 133- 137.
[4] Pierzcha?a A, Kusz D, Widuchowski J. The role of the posterior cruciat ligament in total knee replacement. Ortop Traumatol Rehabil, 2005, 7(6): 666-672.
[5] Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum, 1986, 29(8):1039-1049.
[6] Insall JN, Ranawat CS, Aglietti P, et al. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg(Am),1976, 58(6): 754-765.
[7] Ishii Y, Noguchi H, Matsuda Y, et al. A new tourniquet system that determines pressures in synchrony with systolic blood pressure in total knee arthroplasty. J Arthroplasty. 2008, 23(7): 1050-1056.
[8] Xu GG, Sathappan SS, Jaipaul J, et al. A review of clinical pathway data of 1,663 total knee arthroplasties in a tertiary institution in Singapore. Ann Acad Med Singap- ore, 2008, 37(11): 924-928.
[9] Hernández-Vaquero D, Fernández-Carreira JM, Pérez-Hernández D, et al. Total knee arthroplasty in the elderly. Is there an age limit? J Arthroplasty, 2006, 21(3):358- 361.
[10] Masashi T, Tetsuya T, Tetsu W, et al.In vivo kinematic analysis of high-flexion, posterior-stabilized, mobile-bearing knee prosthesis in deep knee bending motion. J Arthroplasty, 2009, 24(6): 972-978.
[11]翁习生,王炜,高增鑫等.高屈曲度假体与全髁型假体早期临床疗效比较.实用骨科杂志, 2007, 13(1): 25-27.
[12] Sultan PG, Most E, Schule S, et al. Optimizing flexion after total knee arthrop- lasty: advavces in prosthetic design. Clin Orthop Relat Res, 2003, 416(11): 167-173.
[13] Argenson JN, Komistek RD, Mahfouz M, et al. A high flexion total knee arthroplasty design replicates healthy knee motion. Clin Orthop Relat Res, 2004(428): 174-179.
[14] Kawamura H,Bourne RB.Factors affecting range of flexion after total knee arthmplasty. J Orthop Sci, 2007,6(3):248-252
[15] Huang HT, Su JY, Wang GJ. The early results of high-flex total knee arthroplasty: a minimum of 2 years of follow-up. J Arthroplasty, 2005, 20(5): 674-679.
[16] Mehin R, Burnett RS, Brasher PM..Does the new generation of high-flex knee prostheses improve the post-operative range of movement?: a meta-analysis. J Bone Joint Surg(Br), 2010, 92(10): 1429-1434.
[17] Moon YW, Seo JG, Chang MJ, et al. Minimum five-year follow-up results of single-radius, high-flex posterior-stabilized TKA[J]. Orthopedics, 2010, 33(10): 155- 159
[18] Schurman DJ. Matityahu A, Goodman SB, et al. Prediction of postoperative knee flexion in Insall-Burstein II total knee arthroplasty[J]. Clin Orthop Relat Res, 1998(353): 175-184.
[19] Ritter MA. High-flexion knee designs:more hype than hope? In theaffirmative[J]. J Arthroplasty, 2006, 21(4): 40-41
[20] Walker PS, Garg A. Range of motion in total knee arthroplasty:A computer analysis[J]. Clin Orthop Relat Res, 1991,(262): 227-235.
[21] Sultan PG, Most E, Schule S, et al. Optimizing flexion after total knee arthroplasty: advavces in prosthetic design[J]. Clin Orthop Relat Res, 2003, 416(11): 167-173.
[22] Bengs BC, Scott RD. The effect of patellar thickness on intraoperative knee flexion and patellar tracking in total knee arthroplasty[J]. J Arthroplasty, 2006, 21(5) :650 -655.
[23] Berend KR, Lombardi AV, Adams Jg. Total knee arthroplasty in patients with greater than 20 degrees flexion contracture[J]. Clin Orthop Relat Res, 2006, 452(1): 83-87.
[24] Anouchi YS, McShane M, Kelly FJ, et a1. Range of motion in total knee replacement[J]. Clin Orthop,1996,(331):87-92.
[25]吕厚山.当前膝关节置换存在的问题与思考.中华关节外科杂志(电子版), 2007, 1(4): 193-196.
[26] Calvisi V, Camillieri G, Lupparelli S. Resurfacing versus non resurfacing the patella in total knee arthroplasty: a critical appraisal of the available evidence. Arch Orthop Trauma Surg, 2009,129(9):1261-1270·
[37]Park Sj, Jung Yb, Jeong Hj, Et Al. Long-term results of primary total knee arthroplasty with and without patellar resurfacing. Acta Med Okayama, 2010, 64(5): 331-338.
[28] Pakos Ee, Ntzani Ee, Trikalinos Ta. Patellar resurfacing in total knee arthroplasty.a meta-analysis. J Bone Joint Surg(Am), 2005, 87(7): 1438-1445·
[29]He Jy, Jiang Ls, Dai Ly. Is patellar resurfacing superior than nonresurfacing in total knee arthroplasty?a meta-analysis of randomized trials. Knee, 2010(19), 1-8
[30] Epinette Ja,Manley Mt. Outcomes of patellar resurfacing versus nonresurfacing in total knee arthroplasty: a 9-year experience based on a case series of scorpio ps knees. J Knee Surg, 2008, 21(4): 293-298.
[31] Burnett Rs, Boone Jl, Rosenzweig Sd, et al. Patellar resurfacing compared with nonresurfacing in total knee arthroplasty. a Concise Follow-Up Of a Randomized Trial. J Bone Joint Surg(Am), 2009, 91(11): 2562-2567.
[32] Lehner B, Koeck FX, Capellino S, Schubert TE, et al. Preponderance of sensory versus sympathetic nerve fibers and increased cellularity in the infrapatellar fat pad in anterior knee pain patients after primary arthroplasty. Orthop Res, 2008, 26(3): 342-50.
[33] Bohnsack M, Meier F, Walter GF, et al. Distribution of substance-P nerves inside the infrapatellar fat pad and the adjacent synovial tissue: a neurohistological approach to anterior knee pain syndrome. Arch Orthop Trauma Surg, 2005, 125(9): 592-597.
[34] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. Instr Course Lect, 2004, (53):167-186.
[35] Rodriguez-Merchan EC, Gomez-Cardero P. The outerbridge classification predicts the need for patellar resurfacing in TKA. Clin Orthop Relat Res, 2010, 468(5): 1254–1257.
[36] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010,17(3):187-190.
[37] Lee GC, Cushner FD, Scuderi GR,et al. Optimizing patellofemoral tracking during total knee arthroplasty.J Knee Surg, 2004,17(3): 144-149.
[38]张斌,吕厚山.髌骨表面置换术中髌骨骨床保留厚度的探讨.中华骨科杂志, 2002, 22(5): 280-283.
[39]Lim JT, Luscombe KL, Jones PW, et al. The effect of preoperative symptomseverity on functional outcome of total knee replacement--patients with the lowest preoperative scores achieve the lowest marks. Knee, 2006, 13(3):216-219.
[40]王昆,温晓粤,刘斌,等.膝关节骨关节炎全膝关节置换术后疗效影响因素的分析.中华关节外科杂志(电子版), 2008, 2(5): 521-527.
[41] Stickles B, Phillips L, Brox WT, et al. Defining the relationship between obesity and total joint arthroplasty. Obesity Research, 2001, (9): 219-223.
[42] Parvizi J, Mui A, Purtill JJ, Sharkey PF, et al. Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg(Am), 2007, 89(1):27-32.
[43] Hernández-Vaquero D, Femández-Carreira JM, Pérez-Hernández D. Total knee arthroplasty in the elderly, Is there an age limit? J Arthroplasty, 2006, 21(3):358- 361.
[44] Cheng YJ, Chien CT, Chen CF. Oxidative stress in bilateral to-tal knee replacement, under ischaemic tourniquet. J BoneJoint Surg(Br), 2003, 85(5): 679- 682.
[45] Merle-Vincent F, Couris CM, Schott AM, et al. Cross-sectional study of pain and disability at knee replacement surgery for osteoarthritis in 299 patients. Joint Bone Spine, 2007, 74(6):612-616.
[46] Elson DW, Brenkel IJ. Predicting pain after total knee arthroplasty. J Arthroplasty, 2006, 21(7):1047-1053.
[47] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010, 17(3): 187-190.
[48] Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop (Belle Mead NJ), 2004, 33(2): 85-92.
[49] Wittstein JR, O'Brien SD, Vinson EN, et al. MRI evaluation of anterior knee pain: predicting response to nonoperative treatment. Skeletal Radiol, 2009,38(9):895-901.
[50] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[51] Dale H, Hallan G, Hallan G, et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop, 2009, 80(6): 639-645.
[52] Dennis DA, Channer M. Retained distal femoral osteophyte. An infrequent cause of postoperative pain following total knee arthroplasty. J Arthroplasty, 1992, 7(2):193-195.
[53] Lintner DM, Bocell JR, Tullos HS. Arthroscopic treatment of intraarticular fibrous bands after total knee arthroplasty. A followup note. Clin Orthop Relat Res, 1994, (309): 230-233.
[54] Barrack RL, Brumfield CS, Rorabeck CH, et al. Heterotopic ossification after revision total knee arthroplasty. Clin Orthop Relat Res, 2002, (404): 208-213.
[55] Barnes CL, Scott RD. Popliteus tendon dysfunction following total knee arthroplasty. J Arthroplasty, 1995, 10(4): 543-545.
[56] Brown EC 3rd, Clarke HD, Scuderi GR. The painful total knee arthroplasty: diagnosis and management. Orthopedics, 2006, 29(2): 129-36.
[57]吕厚山.人工膝关节置换术后疼痛原因分析.中华医学会第十届骨科学术会议暨第三届国际COA学术大会骨科教程.北京. 2009. 93-100.
[58]张启栋,郭万首,张倩,等.膝关节置换术中髌骨置换与非髌骨置换比较的Meta分析.中国矫形外科杂志, 2010, 18(1):17-21.
[59] MaheshwariAV, Blum YC, ShekharL, et al. Multimodalpainmanagementafter totalhip and knee arthroplasty at the Ranawat Orthopaedic Center. Clin Orthop Relat Res, 2009, 467(6): 1418-1423.
[60] Kim YH, Kim JS. Incidence and natural history of deep-veinthrombosis after total knee arthroplasty,a prospective, randomized study. J Bone Joint Surg(Br), 2002,(84): 566-570.
[61] EdmondsMJ, Crichton TJ, RuncimanWB, et al. Evidence-based risk factorsfor postoperative deep vein thrombosis. ANZ J Surg, 2004, 74 (12):1082-1097.
[62] Kearon D, Diangosis of pulmonary embolism. CMAJ, 2003, 168(2): 183-194.
[63]郭丹杰,胡大一,周伟荣,等.急性肺栓塞诊断治疗的临床分析和探讨.中华心血管病杂志, 2003, 31(1): 49-51.
[64] Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J, 2000, 21(16): 1301-1336.
[65] Roy PM. Diagnosis of venous thromboembolism. Eur J Vasc Endovasc Surg, 2010, 40(5): 664-668.
[66] Bierry G, Holl N, Kellner F, et al. Venous thromboembolism and occult malignancy: simultaneous detection during pulmonary CT angiography with CT venography. AJR Am J Roentgenol, 2008, 191(3):885-889.
[67] TorbickiA, PerrierA,Konstantinides S, et al. Guidelineson the diagnosis and management of acute pulmonaryembolism: the task force for the diagnosis andmanagement of acute pulmonary embolism of theeuropean society of cardiology (ESC). Eur Heart J, 2008, 29(18): 2276-2315.
[68] Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg, 1993, 36(4): 359-364.
[69] Machlus KR, Aleman MM, Wolberg AS. Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arterioscler Thromb Vasc Biol, 2011, 31(3): 476-478.
[70]沈延东,郑慷,章慧斌.高龄髋关节置换术后深静脉血栓形成的防治. 2006, 12(2): 108-109.
[71] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospitalcomplications andmortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res, 2008, 466(11): 2617-2627.
[72] Moore JM. Epiduralanalgesia and clini-cal outcomes. seminars in anesthesia[J]. PerioperativeMedicine and Pain,2003, 22(3): 197-208.
[73] Michiels JJ. Rational diagnosis of pulmonary embolism (RADIA PE) in symptomatic outpatients with suspected PE: an improved strategy to exclude or diagnose venous thromboembolism by the sequential use of a clinical model, rapid ELISA D-dimer test, perfusion lung scan, ultrasonography, spiral CT, and pulmonary angiography. Semin Thromb Hemost, 1998, 24(4): 413-418.
[74] Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 1999, 353(9162): 1386-1389.
[75] Ishihara K, Hiromatsu S, Shintani Y, et al. Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein. Surg Today, 2009, 39(9): 764-769.
[76] Lotke PA.The rule of aspirin for thromboembolic disease in total joint arthroplasty. Am J Knee Surg, 1999, 12(1): 61-63.
[77] Lotke PA,Lronner JH.The Benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty.Clini Orthop Relat Res,2006,452(11):175-180.
[78] Enyart JJ,Jones RJ.Low-dose warfarin for prevent ion of symptomatic thromboembolism after orthopedic surgery.Ann Pharmacother, 2005, 39(6): 1002-1007.
[79] Geerts WH,Pineo GF,Heir JA,et al.Prevention of venous thromboembolism:the seventh ACCP conference on antit hrombotic and thrombolytic therapy. Chest, 2004, 126(3): 338-400.
[80] Thames BC,Allen DO.AANA Journal course:Update for nurse anesthetists-low molecular weight heparin:pharmacology and regional anesthetic. AANA J, 2000, 68(4): 357-364.
[81] Zacharski LR, Prandoni P,Monreal M.Warfarin versus low-molecular-weight heparin therapy in cancer patients.Oncologist, 2005, 10(1): 72-79.
[82] Eriksson BI, Dahl OE, Roseneher N, et al.Dabigatran etexilate versus enoxaParin for prevention of venous thromboembolism atter total hip replaeement:a randomised, double-blind, non-inferiority trial. Lancet, 2007, 370(9591): 949-956.
[83] Eriksson BI, Dahl OE, Roseneher N, etal.Oral dabigatran etexilate vs.subeutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost, 2007, 5(11):2178-2185.
[84] Kakkar AK, Brenner B, Dahl OE, et al.Extended duration rivaroxaban versus short-term enoxaparin for the prevention ofvenous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet, 2008,372(9632):31-39.
[85] Lassen MR,Ageno W,Borris LC,et al.Rivarosaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J med, 2008, 358(26): 2776-2786.
[86] Piccini JP, Patel MR, Mahaffey KW, etal. Rivaroxaban, an oral direct factor Xa inhibitor. Expert Opin Investig Drugs, 2008, 17(6): 925-937.
[87] Chotanaphuti T, Ongnamthip P, Silpipat S, et al. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai, 2007, 90(7): 1342-1347.
[88] Gelfer Y, Tavor H, Oron A ,et al. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low-molecular-weightheparin. J Arthroplasty, 2006, 21(2): 206-214.
[89] Clifford W, Colwell JR, Mark I, et al. Thrombosis prevention after total hip arthroplasty: A prospective,randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg(Am), 2010; 92(3): 527-535.
[90] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospital complications andmortality ofunilateral, bilateral,and revision TKA: based on an estimate of4,159,661discharges. Clin OrthopRelatRes, 2008, 466(11):2617-2627.
[91] ParviziJ, Ghanem E, SharkeyP, et al. Diagnosis ofinfected total knee: findings ofa multicenterdatabase. Clin OrthopRelatRes, 2008, 466(11): 2628-2633.
[92] Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res, 2001, (392):15-23.
[93] Garvin KL, Hanssen AD. Infection after total hip arthroplasty, past, present, and future. J Bone Joint Surg(Am), 1995, (77):1576-1588.
[94] Urban JA, garunKL. Infection aftertolal hip arthroplasty. Curr Opin Orthop, 2003, 45: 68-71.
[95] Di Cesare P E, Chang E. Serum interleukin26 as a marker ofperip rosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg(Am), 2005 , 87 (9) : 1921-1927.
[96] Spangeh M J, Masri B A, O’Connell J X, et al. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg(Am), 1999, 8l(5): 672-683.
[97] Trampuz A, Steinrücken J, Clauss M, ET AL. New methods for the diagnosis of implant-associated infections]. Borens O.Rev Med Suisse, 2010, 6(243): 731-734.
[98] Lonner JH, Desai P, Dicesare PE, et al . The reliability ofanalysisofintraoperative frozen sectionsfor identirying active infectionduring revisionhip or knee arthroplasty. J Bone Joint Surg(Am), 1996, 78(10): 1553-1158.
[99] Fang-Yao Chiu, Chuan-Mu Chen. Surgical debridement and paranteralantibiotics in infected revision total knee arthroplasty. Clinical Orthopaedics and Related Research, 2007, (461): 130-135.
[100] Bindelglass DF, Dorr LD. Current concepts review: symmetryversus asymmetry in the design of total knee femoral components-an unresolved controversy. J Arthroplasty, 1998, 13(8): 939-944.
[101] Peersman G, Laskin R, Davis J, et al. Infection in totalkneereplacement: a retrospective review of 6489 total knee re-placements. Clin Orthop Relat Res, 2001, (392): 15-23.
[102] Gandhi R, DeBeer J, Leone J, et al. Predictive risk factors for sti kneesin total knee arthroplasty. J Arthroplasty, 2006, 21(1):46-52.
[103] Erkan S, Yercan HS, Okcu G, et al. Factors causing stiff knee after total knee arthroplasty. Eklem Hastalik Cerrahisi, 2011, 22(1): 16-21.
[104] Bong MR, Di Cesare PE. Stiffness after total knee arthroplasty. J Am Acad Orthop Surg, 2004, 12(3):164-71.
[105] Robertsson O, Knutson K, Lewold S, et al·The Swedish knee arthroplasty register 1975~1997 (An update with special em-phasis on 41 233 knees operated on in1988~1997). Acta Orthop Scand, 2001, 72 (5): 503-513.
[106] Lonner JH, Klotz M, Levitz C, et al. Changes in bone density after cemented total knee arthroplasty: influence of stem design. J Arthroplasty, 2001, 16(1): 107-111.
[107] Ader F, Bernard L. Pathophysiology of infection on orthopedic biomaterials. Presse Med, 2005, 34(7): 533-536.
[108] Jian LY, Glant TT, Lark MW, et al. The poten 2tial role of fibroblasts inperiprosthetic osteolysis fibroblast response to titanium particles. J Bone Miner Res, 1995, (10): 1417-1427.
[109] Green TR, Fisher J, Stone M, et al. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials, 1998, 19(24): 2297-2302.
[110] Horowitz SM, Purdon MA. Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants. Calcif Tissue Int, 1995, 57(4): 301-305.
[111] Greenfield M, Bechtold J. What other biologic and mechanical factors might contribute to osteolysis? Am Acad Ortho Surg, 2007, 16 (1) : 56-62.
[112] Laurencin CT, Attawia MA, Lu LQ, et al. Poly(lactide-co-glycolide)/ hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials, 2001, 22(11): 1271-1277.
[113] Kauppila AM, Kyll?nen E, Ohtonen P, et al. Multidisciplinary rehabilitation after primary total knee arthroplasty: a randomized controlled study of its effects on functional capacity and quality of life. Clin Rehabil, 2010, 24(5):398-411.
[114] Cheng N, Shi QY. Rehabilitation exercises after single total knee replacement: a report of 38 cases. Zhongguo Gu Shang, 2010, 23(3): 220-221.
[115]侯来永,王廉,谢欲晓,等.全膝关节置换术后个性化系统康复的疗效观察.中国康复医学杂志, 2008, 23(8):707-710.
[116] Daltroy LH, Morlino CI, Eaton HM, et al. Preoperative education for total hip and knee replacement patients. Arthritis Care Res, 1998, 11(6): 469-478.
[117] Thomas KM, Sethares KA. Is guided imagery effective in reducing pain and anxiety in the postoperative total joint arthroplasty patient? Orthop Nurs, 2010, 29(6): 393-399.
[1] Pavone V, Boettner F, Fickert S, et al. Total condylar knee arthroplasty: a long- term followup. Clin Orthop Relat Res. 2001, 388(7): 18-25.
[2] Worland RL, Johnson GV, Alemparte J,et al. Ten to fourteen year survival and functional analysis of the AGC total knee replacement system. Knee. 2002, 9(2): 133-137.
[3] Pierzcha?a A, Kusz D, Widuchowski J. The role of the posterior cruciate ligament in total knee replacement. Ortop Traumatol Rehabil. 2005, 7(6): 666-672.
[4] Tecklenburg K, Dejour D, Hoser C, et al. Bony and cartilaginous anatomy of the patellofemoral joint. Knee Surg Sports Traumatol Arthrosc, 2006, 14(3): 235-240.
[5] Reider B, Marshall JL, Koslin B, et al. The anterior aspect of the knee joint. J Bone Joint Surg(Am), 1981, 63(3): 351-356.
[6]张磊,刘忠堂,李彬,等.国人髌骨解剖标志点在髌骨置换截骨中意义.中国组织工程研究与临床康复, 2008, 12(17): 3241-3244.
[7]徐斌,吕厚山,燕太强.正常髌骨厚度的测量及临床意义探讨.中国临床解剖学杂志, 2001, 19(2): 157-158.
[8] Senavongse W, Farahmand F, Jones J, et al. Quantitative measurement of patellofemoral joint stability: force-displacement behavior of the human patella in vitro. J Orthop Res, 2003, 21(5): 780-786.
[9] Townley CO. Total knee arthroplasty. A personal retrospective and prospective review. Clin Orthop Relat Res, 1988, (236): 8-22.
[10]Wibeeg G. Roentgenographs and Anatomic Studies on the Femoropatellar Joint: With Special Reference to Chondromalacia Patellae. Acta Orthop Scand, 1941, 12(1): 319- 410.
[11] Haag C, Merkle K. Clinical and radiologic results of surgically treated patellar dislocation]. Unfallchirurgie, 1997, 23(5): 210-215.
[12] Berg EE, Mason SL, Lucas MJ. Patellar height ratios. A comparison of four measurement methods. Am J Sports Med, 1996, 24(2): 218-221.
[13]罗吉伟,黄美贤,史占军,等.华南地区人髌骨Wiberg's和Baumgartl's形态学分型的流行性病学研究.中国临床解剖学杂志, 2007, 25(1): 7-9.
[14]何志勇,吴海山,耿正林,等.国人髌骨形态学研究及其在髌骨假体设计中的意义.中国骨与关节损伤杂志, 2006, 21(8): 611-613.
[15]张磊.国人髌骨的解剖学研究及其在髌骨置换术中的意义. [硕士学位论文].上海:第二军医大学, 2007.
[16]刘锋,陶松年.全膝关节置换术中的髌骨表面置换.江苏医药, 1999, 25(1): 39-40.
[17] Brick GW, Scott RD. The patellofemoral component of total knee arthroplasty. Clin Orthop Relat Res.1988 Jun;(231):163-178.
[18] Grelsamer RP, Weinstein CH. Applied biomechanics of the patella. Clin Orthop Relat Res, 2001, (389): 9-14.
[19] Barrack RL, Burak C. Patella in total knee arthroplasty. Clin Orthop Relat Res, 2001, (389): 62-73.
[20] Redziniak DE, Diduch DR, Mihalko WM, et al. Patellar instability. Instr Course Lect, 2010, (59): 195-206.
[21] Conlan T, Garth WP Jr, Lemons JE. Evaluation of the medial soft-tissue restraints of the extensor mechanism of the knee. J Bone Joint Surg(Am), 1993, 75(5): 682-693.
[22] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. Instr Course Lect, 2004, (53):167-186.
[23] Park SJ, Jung YB, Jeong HJ, et al. Long-term results of primary total knee arthroplasty with and without patellar resurfacing. Acta Med Okayama, 2010, 64(5): 331-338.
[24] Motsis EK, Paschos N, Pakos EE, et al. Review article: Patellar instability after total knee arthroplasty. J Orthop Surg(Hong Kong), 2009, 17(3): 351-357.
[25] Cameron HU, Huffer B. Avascular necrosis of the patella following total knee replacement. Acta Orthop Belg, 1985, 51(5):805-810.
[26] Keating EM, Haas G, Meding JB. Patella fracture after post total knee replacements. Clin Orthop Relat Res, 2003, (416): 93-97.
[27] Swan JD, Stoney JD, Lim K, et al. The need for patellar resurfacing in total knee arthroplasty: a literature review. ANZ J Surg, 2010, 80(4): 223-33.
[28] Merle-Vincent F, Couris CM, Schott AM, et al. Cross-sectional study of pain and disability at knee replacement surgery for osteoarthritis in 299 patients. Joint Bone Spine, 2007, 74(6): 612-616.
[29] Elson DW, Brenkel IJ. Predicting pain after total knee arthroplasty. J Arthroplasty, 2006, 21(7):1047-1053.
[30] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010, 17(3): 187-190.
[31] Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop (Belle Mead NJ), 2004, 33(2): 85-92.
[32] Wittstein JR, O'Brien SD, Vinson EN, et al. MRI evaluation of anterior knee pain: predicting response to nonoperative treatment. Skeletal Radiol, 2009, 38(9): 895-901.
[33] Dale H, Hallan G, Hallan G, et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop, 2009, 80(6): 639-645.
[34] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[35] Dennis DA, Channer M. Retained distal femoral osteophyte. An infrequent cause of postoperative pain following total knee arthroplasty. J Arthroplasty, 1992, 7(2):193-195.
[36] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[37] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. J Bone Joint Surg(Am), 2003, 85(4): 728–745
[38]张启栋,郭万首,张倩,等.膝关节置换术中髌骨置换与非髌骨置换比较的Meta分析.中国矫形外科杂志, 2010, 18(1):17-21.
[39] Waters TS,Bentley G. Patellar resurfacing in total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg(Am).2003, 85(2): 212-217.
[40] Calvisi V, Camillieri G, Lupparelli S. Resurfacing versus nonresurfacing the patella in total knee arthroplasty: a critical appraisal of the available evidence. Arch Orthop Trauma Surg, 2009, 129(9): 1261-1270.
[41] Pakos EE, Ntzani EE, Trikalinos TA. Patellar resurfacing in total knee arthroplasty. A meta-analysis. J Bone Joint Surg(Am), 2005, 87(7): 1438-1445.
[42] Burnett RS, Boone JL, McCarthy KP,et al. A prospective randomized clinical trial of patellar resurfacing and nonresurfacing in bilateral TKA. Clin Orthop Relat Res, 2007, (464): 65-72.
[43]李连华,孙天胜,王静,等.人工全膝关节置换术髌骨置换有效性的系统评价.中国循证医学杂志, 2009, 9(10): 1060-1066.
[44] Gildone A, Manfredini M, Biscione R, et al. Patella resurfacing inposterior stabilised total knee arthroplasty: a follow-up study in 56patients. Acta Orthop Belg, 2005, 71(4): 445-451.
[45] He JY, Jiang LS, Dai LY. Is patellar resurfacing superior than nonresurfacing in total knee arthroplasty? A meta-analysis of randomized trials. Knee, 2011, 18(3): 137-144.
[46] Davidson PA,Rivenburgh D.Focal anatomic patellofemoral inlay resurfacing: theoretic basis, surgical technique, and casereports. Orthop Clin North AM, 2008, 39(3): 337-346.
[47] Tunay S, Ozkan H, K se O, et al.Total knee arthroplasty in a patient with neglected congenital patellar dislocation. Orthropaedic, 2009, 32(10): 818-822.
[48] Aanderson JA,Baldini A,Sculco TP. Patellofemoral function after total knee arthroplasty: a comparison of 2 posterior-stabilized designs.J Knee Surg, 2008, 21(2): 91-96.
[49]翟生,凯塞尔江,武忠炎.全膝关节置换过程中是否行髌骨置换的系统评价.中国组织工程研究与临床康复, 2009, 13(13):2547-2552.
[50] Campbell DG, Duncan WW, Ashworth M, et al. Patellar resurfacing in total knee replacement: a ten-year randomised prospective trial. J Bone Joint Surg Br.2006 Jun;88(6):734-9.
[51]刘帆,吕厚山,闵志松.全膝人工关节置换术中髌骨置换对股四头肌肌力的影响.中华医学杂志, 2008, 88(12): 809-811.
[52] Bellemans J. Restoring the joint line in revision TKA: does it matter? Knee, 2004 Feb;11(1):3-5. Review.
[53] Chonko DJ,Lombardi AV JR, Berend KR. Patella baja and total knee arthroplasty (TKA): etiology, diagnosis, and management. Surg Technol Int, 2004, (12): 231-238.
[54] Fl?ren M, Davis J, Peterson MG, ET AL. A mini-midvastus capsular approach with patellar displacement decreases the prevalence of patella baja. J Arthroplasty, 2007, 22(6 Suppl 2): 51-57.
[55] Ikejiani CE, Leighton R, Petrie DP. Comparison of patellar resurfacing versus nonresurfacing in total knee arthroplasty. Can J Surg, 2000, 43(1): 35-38.
[56] Myles CM, Rowe PJ, Nutton RW, et al. The effect of patella resurfacing in total knee arthroplasty on functional range of movement measured by flexible electrogoniometry. Clin Biomech (Bristol, Avon), 2006, 21(7): 733-739.
[57]金丽颖.髌骨对膝关节运动影响的生物力学分析.山东体育学院学报, 2008, 24(2): 60-61.
[58] Insall JN, Ranawat CS, Aglietti P, et al. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg(Am),1976, 58(6): 754-765.
[59] Insall JN, Dorr LD, Scott RD, et al. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res, 1989, (248):13-14.
[60] Bellamy N. Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum, 1989, 18(4Suppl2):14-17.
[61] Li S, Chen Y, Su W, et al. Systematic review of patellar resurfacing in total knee arthroplasty. Int Orthop, 2011, 35(3): 305-316.
[62] Burnett RS, Boone JL, Rosenzweig SD, et al. Patellar resurfacing compared with nonresurfacing in total knee arthroplasty. A concise follow-up of a randomized trial. J Bone Joint Surg(Am), 2009, 91(11): 2562-2567.
[1] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospital complications andmortality ofunilateral, bilateral,and revision TKA: based on an estimate of4,159,661discharges. Clin OrthopRelatRes, 2008, 466(11):2617-2627.
[2] ParviziJ, Ghanem E, SharkeyP, et al. Diagnosis ofinfected total knee: findings ofa multicenterdatabase. Clin OrthopRelatRes, 2008, 466(11): 2628-2633.
[3] Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am, 1975, 6(4): 991-1003.
[4] Schmalzried TP, Amstutz HC, Au MK, et al. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res, 1992, (280): 200-207.
[5] Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg(Am), 1996 , 78(4): 512-523.
[6] Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly, 2005, 135(17-18): 243-251.
[7] Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retros- pective review of 6489 total knee replacements. Clin Orthop Relat Res, 2001, (392):15-23.
[8] Vince K, Chivas D, Droll KP. Wound Complications after Total Knee Arthropla- sty. J Arthroplasty, 2007, 22(4Suppl1): 39-44.
[9] Hofman AA, Kane KR, Tkach TK, et al. Treatment of infected total knee arthrop- lasty using an articulating spacer. Clin Orthop, 1995, (321): 45-54.
[10] Garvin KL, Hanssen AD. Infection after total hip arthroplasty, past, present, and future. J Bone Joint Surg(Am), 1995, (77):1576-1588.
[11] Urban JA, garunKL. Infection aftertolal hip arthroplasty. Curr Opin Orthop, 2003, (45): 68-71.
[12] Greidanus NV, Masri BA, Garbuz DS, et al. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg(Am), 2007, 89(7): 1409-1416.
[13] Spangeh MJ, Masri BA, O’Connell J X, et al. Prospective analysis of preoperative and in traoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg(Am), 1999, 8l(5): 672-683.
[14] Trampuz A, Steinrücken J, Clauss M, et al. New methods for the diagnosis of implant-associated infections. Borens O.Rev Med Suisse, 2010, 6(243): 731-734.
[15] Lonner JH, Desai P, Dicesare PE, et al. The reliability of analysis of intraoperative frozen sections for identirying active infection during revision hip or knee arthroplasty. J Bone Joint Surg(Am). 1996, 78(10): 1553-1158.
[16] Athanasou NA.Pandey R, deSteiger R, et al. Diagnosis of infection by frozen section during revision arthroplasty. J BoneJoint Surg(Br), 1995, 77(11): 28-33.
[17] Di Cesare P E, Chang E. Serum interleukin26 as a marker ofperip rosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg(Am), 2005 , 87 (9) : 1921-1927.
[18] Bongartz T, Halligan CS, Osmon DR, et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum, 2008, 59(12):1713-1720.
[19] Bolognesi MP, Marchant MH Jr, Viens NA, et al. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty, 2008, 23(6 Suppl 1): 92-98.
[20] American Academy of Orthopaedic Surgeons Patient Safety Committee (AAO SPSC), Evans RP. Surgical site infection prevention and control: an emerging paradigm. Bone Joint Surg(Am), 2009, 91(Suppl6): 2-9.
[21] Kuper M, Rosenstein A. Infection prevention in total knee and total hip arthroplastics. Am J Orthop(Belle Mead NJ), 2008, 37(1):2-5.
[22] Willemen D, Paul J, White SH, et al. Closed suction drainage following knee arthroplasty. Effectiveness and risks. Clin Orthop Relat Res, 1991, (264): 232-234.
[23] Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis, 1998, 27(5):1247-1254.
[24] Parvizi J, Ghanem E, Joshi A, et al. Does "excessive" anticoagulation predispose to periprosthetic infection?J Arthroplasty, 2007, (6 Suppl 2): 24-28.
[25] Chiu FY, Chen CM. Surgical débridement and parenteral antibiotics in infected revision total knee arthroplasty. Clin Orthop Relat Res, 2007, (461): 130-135.
[26] Burnett RS, Kelly MA, Hanssen AD, et al. Technique and timing of two-stage exchange for infection in TKA. Clin Orthop Relat Res, 2007, (464): 164-178.
[27] Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: Current status. Acta Orthop, 2006, 77(4): 628-637.
[28] Blom AW, Brown J, Taylor AM, et al. Infection after total knee arthroplasty. J Bone Joint Surg(Br), 2004, 86(5) :688-691.
[29]周勇刚,肖逸鹏,王岩,等.二期翻修在人工膝关节置换术后感染治疗中的作用.中华关节外科杂志(电子版), 2007, 1(4): 1-5.
[30] Hart WJ, Jones RS. Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy. J Bone Joint Surg Br, 2006, 88(8): 1011-5.
[2] Pavone V, Boettner F, Fickert S, et al. Total condylar knee arthroplasty: a long- term followup. Clin Orthop Relat Res. 2001, 388(7): 18-25.
[3] Worland RL, Johnson GV, Alemparte J, et al. Ten to fourteen year survival and functional analysis of the AGC total knee replacement system. Knee, 2002, 9(2): 133- 137.
[4] Pierzcha?a A, Kusz D, Widuchowski J. The role of the posterior cruciat ligament in total knee replacement. Ortop Traumatol Rehabil, 2005, 7(6): 666-672.
[5] Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum, 1986, 29(8):1039-1049.
[6] Insall JN, Ranawat CS, Aglietti P, et al. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg(Am),1976, 58(6): 754-765.
[7] Ishii Y, Noguchi H, Matsuda Y, et al. A new tourniquet system that determines pressures in synchrony with systolic blood pressure in total knee arthroplasty. J Arthroplasty. 2008, 23(7): 1050-1056.
[8] Xu GG, Sathappan SS, Jaipaul J, et al. A review of clinical pathway data of 1,663 total knee arthroplasties in a tertiary institution in Singapore. Ann Acad Med Singap- ore, 2008, 37(11): 924-928.
[9] Hernández-Vaquero D, Fernández-Carreira JM, Pérez-Hernández D, et al. Total knee arthroplasty in the elderly. Is there an age limit? J Arthroplasty, 2006, 21(3):358- 361.
[10] Masashi T, Tetsuya T, Tetsu W, et al.In vivo kinematic analysis of high-flexion, posterior-stabilized, mobile-bearing knee prosthesis in deep knee bending motion. J Arthroplasty, 2009, 24(6): 972-978.
[11]翁习生,王炜,高增鑫等.高屈曲度假体与全髁型假体早期临床疗效比较.实用骨科杂志, 2007, 13(1): 25-27.
[12] Sultan PG, Most E, Schule S, et al. Optimizing flexion after total knee arthrop- lasty: advavces in prosthetic design. Clin Orthop Relat Res, 2003, 416(11): 167-173.
[13] Argenson JN, Komistek RD, Mahfouz M, et al. A high flexion total knee arthroplasty design replicates healthy knee motion. Clin Orthop Relat Res, 2004(428): 174-179.
[14] Kawamura H,Bourne RB.Factors affecting range of flexion after total knee arthmplasty. J Orthop Sci, 2007,6(3):248-252
[15] Huang HT, Su JY, Wang GJ. The early results of high-flex total knee arthroplasty: a minimum of 2 years of follow-up. J Arthroplasty, 2005, 20(5): 674-679.
[16] Mehin R, Burnett RS, Brasher PM..Does the new generation of high-flex knee prostheses improve the post-operative range of movement?: a meta-analysis. J Bone Joint Surg(Br), 2010, 92(10): 1429-1434.
[17] Moon YW, Seo JG, Chang MJ, et al. Minimum five-year follow-up results of single-radius, high-flex posterior-stabilized TKA[J]. Orthopedics, 2010, 33(10): 155- 159
[18] Schurman DJ. Matityahu A, Goodman SB, et al. Prediction of postoperative knee flexion in Insall-Burstein II total knee arthroplasty[J]. Clin Orthop Relat Res, 1998(353): 175-184.
[19] Ritter MA. High-flexion knee designs:more hype than hope? In theaffirmative[J]. J Arthroplasty, 2006, 21(4): 40-41
[20] Walker PS, Garg A. Range of motion in total knee arthroplasty:A computer analysis[J]. Clin Orthop Relat Res, 1991,(262): 227-235.
[21] Sultan PG, Most E, Schule S, et al. Optimizing flexion after total knee arthroplasty: advavces in prosthetic design[J]. Clin Orthop Relat Res, 2003, 416(11): 167-173.
[22] Bengs BC, Scott RD. The effect of patellar thickness on intraoperative knee flexion and patellar tracking in total knee arthroplasty[J]. J Arthroplasty, 2006, 21(5) :650 -655.
[23] Berend KR, Lombardi AV, Adams Jg. Total knee arthroplasty in patients with greater than 20 degrees flexion contracture[J]. Clin Orthop Relat Res, 2006, 452(1): 83-87.
[24] Anouchi YS, McShane M, Kelly FJ, et a1. Range of motion in total knee replacement[J]. Clin Orthop,1996,(331):87-92.
[25]吕厚山.当前膝关节置换存在的问题与思考.中华关节外科杂志(电子版), 2007, 1(4): 193-196.
[26] Calvisi V, Camillieri G, Lupparelli S. Resurfacing versus non resurfacing the patella in total knee arthroplasty: a critical appraisal of the available evidence. Arch Orthop Trauma Surg, 2009,129(9):1261-1270·
[37]Park Sj, Jung Yb, Jeong Hj, Et Al. Long-term results of primary total knee arthroplasty with and without patellar resurfacing. Acta Med Okayama, 2010, 64(5): 331-338.
[28] Pakos Ee, Ntzani Ee, Trikalinos Ta. Patellar resurfacing in total knee arthroplasty.a meta-analysis. J Bone Joint Surg(Am), 2005, 87(7): 1438-1445·
[29]He Jy, Jiang Ls, Dai Ly. Is patellar resurfacing superior than nonresurfacing in total knee arthroplasty?a meta-analysis of randomized trials. Knee, 2010(19), 1-8
[30] Epinette Ja,Manley Mt. Outcomes of patellar resurfacing versus nonresurfacing in total knee arthroplasty: a 9-year experience based on a case series of scorpio ps knees. J Knee Surg, 2008, 21(4): 293-298.
[31] Burnett Rs, Boone Jl, Rosenzweig Sd, et al. Patellar resurfacing compared with nonresurfacing in total knee arthroplasty. a Concise Follow-Up Of a Randomized Trial. J Bone Joint Surg(Am), 2009, 91(11): 2562-2567.
[32] Lehner B, Koeck FX, Capellino S, Schubert TE, et al. Preponderance of sensory versus sympathetic nerve fibers and increased cellularity in the infrapatellar fat pad in anterior knee pain patients after primary arthroplasty. Orthop Res, 2008, 26(3): 342-50.
[33] Bohnsack M, Meier F, Walter GF, et al. Distribution of substance-P nerves inside the infrapatellar fat pad and the adjacent synovial tissue: a neurohistological approach to anterior knee pain syndrome. Arch Orthop Trauma Surg, 2005, 125(9): 592-597.
[34] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. Instr Course Lect, 2004, (53):167-186.
[35] Rodriguez-Merchan EC, Gomez-Cardero P. The outerbridge classification predicts the need for patellar resurfacing in TKA. Clin Orthop Relat Res, 2010, 468(5): 1254–1257.
[36] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010,17(3):187-190.
[37] Lee GC, Cushner FD, Scuderi GR,et al. Optimizing patellofemoral tracking during total knee arthroplasty.J Knee Surg, 2004,17(3): 144-149.
[38]张斌,吕厚山.髌骨表面置换术中髌骨骨床保留厚度的探讨.中华骨科杂志, 2002, 22(5): 280-283.
[39]Lim JT, Luscombe KL, Jones PW, et al. The effect of preoperative symptomseverity on functional outcome of total knee replacement--patients with the lowest preoperative scores achieve the lowest marks. Knee, 2006, 13(3):216-219.
[40]王昆,温晓粤,刘斌,等.膝关节骨关节炎全膝关节置换术后疗效影响因素的分析.中华关节外科杂志(电子版), 2008, 2(5): 521-527.
[41] Stickles B, Phillips L, Brox WT, et al. Defining the relationship between obesity and total joint arthroplasty. Obesity Research, 2001, (9): 219-223.
[42] Parvizi J, Mui A, Purtill JJ, Sharkey PF, et al. Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg(Am), 2007, 89(1):27-32.
[43] Hernández-Vaquero D, Femández-Carreira JM, Pérez-Hernández D. Total knee arthroplasty in the elderly, Is there an age limit? J Arthroplasty, 2006, 21(3):358- 361.
[44] Cheng YJ, Chien CT, Chen CF. Oxidative stress in bilateral to-tal knee replacement, under ischaemic tourniquet. J BoneJoint Surg(Br), 2003, 85(5): 679- 682.
[45] Merle-Vincent F, Couris CM, Schott AM, et al. Cross-sectional study of pain and disability at knee replacement surgery for osteoarthritis in 299 patients. Joint Bone Spine, 2007, 74(6):612-616.
[46] Elson DW, Brenkel IJ. Predicting pain after total knee arthroplasty. J Arthroplasty, 2006, 21(7):1047-1053.
[47] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010, 17(3): 187-190.
[48] Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop (Belle Mead NJ), 2004, 33(2): 85-92.
[49] Wittstein JR, O'Brien SD, Vinson EN, et al. MRI evaluation of anterior knee pain: predicting response to nonoperative treatment. Skeletal Radiol, 2009,38(9):895-901.
[50] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[51] Dale H, Hallan G, Hallan G, et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop, 2009, 80(6): 639-645.
[52] Dennis DA, Channer M. Retained distal femoral osteophyte. An infrequent cause of postoperative pain following total knee arthroplasty. J Arthroplasty, 1992, 7(2):193-195.
[53] Lintner DM, Bocell JR, Tullos HS. Arthroscopic treatment of intraarticular fibrous bands after total knee arthroplasty. A followup note. Clin Orthop Relat Res, 1994, (309): 230-233.
[54] Barrack RL, Brumfield CS, Rorabeck CH, et al. Heterotopic ossification after revision total knee arthroplasty. Clin Orthop Relat Res, 2002, (404): 208-213.
[55] Barnes CL, Scott RD. Popliteus tendon dysfunction following total knee arthroplasty. J Arthroplasty, 1995, 10(4): 543-545.
[56] Brown EC 3rd, Clarke HD, Scuderi GR. The painful total knee arthroplasty: diagnosis and management. Orthopedics, 2006, 29(2): 129-36.
[57]吕厚山.人工膝关节置换术后疼痛原因分析.中华医学会第十届骨科学术会议暨第三届国际COA学术大会骨科教程.北京. 2009. 93-100.
[58]张启栋,郭万首,张倩,等.膝关节置换术中髌骨置换与非髌骨置换比较的Meta分析.中国矫形外科杂志, 2010, 18(1):17-21.
[59] MaheshwariAV, Blum YC, ShekharL, et al. Multimodalpainmanagementafter totalhip and knee arthroplasty at the Ranawat Orthopaedic Center. Clin Orthop Relat Res, 2009, 467(6): 1418-1423.
[60] Kim YH, Kim JS. Incidence and natural history of deep-veinthrombosis after total knee arthroplasty,a prospective, randomized study. J Bone Joint Surg(Br), 2002,(84): 566-570.
[61] EdmondsMJ, Crichton TJ, RuncimanWB, et al. Evidence-based risk factorsfor postoperative deep vein thrombosis. ANZ J Surg, 2004, 74 (12):1082-1097.
[62] Kearon D, Diangosis of pulmonary embolism. CMAJ, 2003, 168(2): 183-194.
[63]郭丹杰,胡大一,周伟荣,等.急性肺栓塞诊断治疗的临床分析和探讨.中华心血管病杂志, 2003, 31(1): 49-51.
[64] Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J, 2000, 21(16): 1301-1336.
[65] Roy PM. Diagnosis of venous thromboembolism. Eur J Vasc Endovasc Surg, 2010, 40(5): 664-668.
[66] Bierry G, Holl N, Kellner F, et al. Venous thromboembolism and occult malignancy: simultaneous detection during pulmonary CT angiography with CT venography. AJR Am J Roentgenol, 2008, 191(3):885-889.
[67] TorbickiA, PerrierA,Konstantinides S, et al. Guidelineson the diagnosis and management of acute pulmonaryembolism: the task force for the diagnosis andmanagement of acute pulmonary embolism of theeuropean society of cardiology (ESC). Eur Heart J, 2008, 29(18): 2276-2315.
[68] Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg, 1993, 36(4): 359-364.
[69] Machlus KR, Aleman MM, Wolberg AS. Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arterioscler Thromb Vasc Biol, 2011, 31(3): 476-478.
[70]沈延东,郑慷,章慧斌.高龄髋关节置换术后深静脉血栓形成的防治. 2006, 12(2): 108-109.
[71] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospitalcomplications andmortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res, 2008, 466(11): 2617-2627.
[72] Moore JM. Epiduralanalgesia and clini-cal outcomes. seminars in anesthesia[J]. PerioperativeMedicine and Pain,2003, 22(3): 197-208.
[73] Michiels JJ. Rational diagnosis of pulmonary embolism (RADIA PE) in symptomatic outpatients with suspected PE: an improved strategy to exclude or diagnose venous thromboembolism by the sequential use of a clinical model, rapid ELISA D-dimer test, perfusion lung scan, ultrasonography, spiral CT, and pulmonary angiography. Semin Thromb Hemost, 1998, 24(4): 413-418.
[74] Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 1999, 353(9162): 1386-1389.
[75] Ishihara K, Hiromatsu S, Shintani Y, et al. Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein. Surg Today, 2009, 39(9): 764-769.
[76] Lotke PA.The rule of aspirin for thromboembolic disease in total joint arthroplasty. Am J Knee Surg, 1999, 12(1): 61-63.
[77] Lotke PA,Lronner JH.The Benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty.Clini Orthop Relat Res,2006,452(11):175-180.
[78] Enyart JJ,Jones RJ.Low-dose warfarin for prevent ion of symptomatic thromboembolism after orthopedic surgery.Ann Pharmacother, 2005, 39(6): 1002-1007.
[79] Geerts WH,Pineo GF,Heir JA,et al.Prevention of venous thromboembolism:the seventh ACCP conference on antit hrombotic and thrombolytic therapy. Chest, 2004, 126(3): 338-400.
[80] Thames BC,Allen DO.AANA Journal course:Update for nurse anesthetists-low molecular weight heparin:pharmacology and regional anesthetic. AANA J, 2000, 68(4): 357-364.
[81] Zacharski LR, Prandoni P,Monreal M.Warfarin versus low-molecular-weight heparin therapy in cancer patients.Oncologist, 2005, 10(1): 72-79.
[82] Eriksson BI, Dahl OE, Roseneher N, et al.Dabigatran etexilate versus enoxaParin for prevention of venous thromboembolism atter total hip replaeement:a randomised, double-blind, non-inferiority trial. Lancet, 2007, 370(9591): 949-956.
[83] Eriksson BI, Dahl OE, Roseneher N, etal.Oral dabigatran etexilate vs.subeutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost, 2007, 5(11):2178-2185.
[84] Kakkar AK, Brenner B, Dahl OE, et al.Extended duration rivaroxaban versus short-term enoxaparin for the prevention ofvenous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet, 2008,372(9632):31-39.
[85] Lassen MR,Ageno W,Borris LC,et al.Rivarosaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J med, 2008, 358(26): 2776-2786.
[86] Piccini JP, Patel MR, Mahaffey KW, etal. Rivaroxaban, an oral direct factor Xa inhibitor. Expert Opin Investig Drugs, 2008, 17(6): 925-937.
[87] Chotanaphuti T, Ongnamthip P, Silpipat S, et al. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai, 2007, 90(7): 1342-1347.
[88] Gelfer Y, Tavor H, Oron A ,et al. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low-molecular-weightheparin. J Arthroplasty, 2006, 21(2): 206-214.
[89] Clifford W, Colwell JR, Mark I, et al. Thrombosis prevention after total hip arthroplasty: A prospective,randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg(Am), 2010; 92(3): 527-535.
[90] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospital complications andmortality ofunilateral, bilateral,and revision TKA: based on an estimate of4,159,661discharges. Clin OrthopRelatRes, 2008, 466(11):2617-2627.
[91] ParviziJ, Ghanem E, SharkeyP, et al. Diagnosis ofinfected total knee: findings ofa multicenterdatabase. Clin OrthopRelatRes, 2008, 466(11): 2628-2633.
[92] Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res, 2001, (392):15-23.
[93] Garvin KL, Hanssen AD. Infection after total hip arthroplasty, past, present, and future. J Bone Joint Surg(Am), 1995, (77):1576-1588.
[94] Urban JA, garunKL. Infection aftertolal hip arthroplasty. Curr Opin Orthop, 2003, 45: 68-71.
[95] Di Cesare P E, Chang E. Serum interleukin26 as a marker ofperip rosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg(Am), 2005 , 87 (9) : 1921-1927.
[96] Spangeh M J, Masri B A, O’Connell J X, et al. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg(Am), 1999, 8l(5): 672-683.
[97] Trampuz A, Steinrücken J, Clauss M, ET AL. New methods for the diagnosis of implant-associated infections]. Borens O.Rev Med Suisse, 2010, 6(243): 731-734.
[98] Lonner JH, Desai P, Dicesare PE, et al . The reliability ofanalysisofintraoperative frozen sectionsfor identirying active infectionduring revisionhip or knee arthroplasty. J Bone Joint Surg(Am), 1996, 78(10): 1553-1158.
[99] Fang-Yao Chiu, Chuan-Mu Chen. Surgical debridement and paranteralantibiotics in infected revision total knee arthroplasty. Clinical Orthopaedics and Related Research, 2007, (461): 130-135.
[100] Bindelglass DF, Dorr LD. Current concepts review: symmetryversus asymmetry in the design of total knee femoral components-an unresolved controversy. J Arthroplasty, 1998, 13(8): 939-944.
[101] Peersman G, Laskin R, Davis J, et al. Infection in totalkneereplacement: a retrospective review of 6489 total knee re-placements. Clin Orthop Relat Res, 2001, (392): 15-23.
[102] Gandhi R, DeBeer J, Leone J, et al. Predictive risk factors for sti kneesin total knee arthroplasty. J Arthroplasty, 2006, 21(1):46-52.
[103] Erkan S, Yercan HS, Okcu G, et al. Factors causing stiff knee after total knee arthroplasty. Eklem Hastalik Cerrahisi, 2011, 22(1): 16-21.
[104] Bong MR, Di Cesare PE. Stiffness after total knee arthroplasty. J Am Acad Orthop Surg, 2004, 12(3):164-71.
[105] Robertsson O, Knutson K, Lewold S, et al·The Swedish knee arthroplasty register 1975~1997 (An update with special em-phasis on 41 233 knees operated on in1988~1997). Acta Orthop Scand, 2001, 72 (5): 503-513.
[106] Lonner JH, Klotz M, Levitz C, et al. Changes in bone density after cemented total knee arthroplasty: influence of stem design. J Arthroplasty, 2001, 16(1): 107-111.
[107] Ader F, Bernard L. Pathophysiology of infection on orthopedic biomaterials. Presse Med, 2005, 34(7): 533-536.
[108] Jian LY, Glant TT, Lark MW, et al. The poten 2tial role of fibroblasts inperiprosthetic osteolysis fibroblast response to titanium particles. J Bone Miner Res, 1995, (10): 1417-1427.
[109] Green TR, Fisher J, Stone M, et al. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials, 1998, 19(24): 2297-2302.
[110] Horowitz SM, Purdon MA. Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants. Calcif Tissue Int, 1995, 57(4): 301-305.
[111] Greenfield M, Bechtold J. What other biologic and mechanical factors might contribute to osteolysis? Am Acad Ortho Surg, 2007, 16 (1) : 56-62.
[112] Laurencin CT, Attawia MA, Lu LQ, et al. Poly(lactide-co-glycolide)/ hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials, 2001, 22(11): 1271-1277.
[113] Kauppila AM, Kyll?nen E, Ohtonen P, et al. Multidisciplinary rehabilitation after primary total knee arthroplasty: a randomized controlled study of its effects on functional capacity and quality of life. Clin Rehabil, 2010, 24(5):398-411.
[114] Cheng N, Shi QY. Rehabilitation exercises after single total knee replacement: a report of 38 cases. Zhongguo Gu Shang, 2010, 23(3): 220-221.
[115]侯来永,王廉,谢欲晓,等.全膝关节置换术后个性化系统康复的疗效观察.中国康复医学杂志, 2008, 23(8):707-710.
[116] Daltroy LH, Morlino CI, Eaton HM, et al. Preoperative education for total hip and knee replacement patients. Arthritis Care Res, 1998, 11(6): 469-478.
[117] Thomas KM, Sethares KA. Is guided imagery effective in reducing pain and anxiety in the postoperative total joint arthroplasty patient? Orthop Nurs, 2010, 29(6): 393-399.
[1] Pavone V, Boettner F, Fickert S, et al. Total condylar knee arthroplasty: a long- term followup. Clin Orthop Relat Res. 2001, 388(7): 18-25.
[2] Worland RL, Johnson GV, Alemparte J,et al. Ten to fourteen year survival and functional analysis of the AGC total knee replacement system. Knee. 2002, 9(2): 133-137.
[3] Pierzcha?a A, Kusz D, Widuchowski J. The role of the posterior cruciate ligament in total knee replacement. Ortop Traumatol Rehabil. 2005, 7(6): 666-672.
[4] Tecklenburg K, Dejour D, Hoser C, et al. Bony and cartilaginous anatomy of the patellofemoral joint. Knee Surg Sports Traumatol Arthrosc, 2006, 14(3): 235-240.
[5] Reider B, Marshall JL, Koslin B, et al. The anterior aspect of the knee joint. J Bone Joint Surg(Am), 1981, 63(3): 351-356.
[6]张磊,刘忠堂,李彬,等.国人髌骨解剖标志点在髌骨置换截骨中意义.中国组织工程研究与临床康复, 2008, 12(17): 3241-3244.
[7]徐斌,吕厚山,燕太强.正常髌骨厚度的测量及临床意义探讨.中国临床解剖学杂志, 2001, 19(2): 157-158.
[8] Senavongse W, Farahmand F, Jones J, et al. Quantitative measurement of patellofemoral joint stability: force-displacement behavior of the human patella in vitro. J Orthop Res, 2003, 21(5): 780-786.
[9] Townley CO. Total knee arthroplasty. A personal retrospective and prospective review. Clin Orthop Relat Res, 1988, (236): 8-22.
[10]Wibeeg G. Roentgenographs and Anatomic Studies on the Femoropatellar Joint: With Special Reference to Chondromalacia Patellae. Acta Orthop Scand, 1941, 12(1): 319- 410.
[11] Haag C, Merkle K. Clinical and radiologic results of surgically treated patellar dislocation]. Unfallchirurgie, 1997, 23(5): 210-215.
[12] Berg EE, Mason SL, Lucas MJ. Patellar height ratios. A comparison of four measurement methods. Am J Sports Med, 1996, 24(2): 218-221.
[13]罗吉伟,黄美贤,史占军,等.华南地区人髌骨Wiberg's和Baumgartl's形态学分型的流行性病学研究.中国临床解剖学杂志, 2007, 25(1): 7-9.
[14]何志勇,吴海山,耿正林,等.国人髌骨形态学研究及其在髌骨假体设计中的意义.中国骨与关节损伤杂志, 2006, 21(8): 611-613.
[15]张磊.国人髌骨的解剖学研究及其在髌骨置换术中的意义. [硕士学位论文].上海:第二军医大学, 2007.
[16]刘锋,陶松年.全膝关节置换术中的髌骨表面置换.江苏医药, 1999, 25(1): 39-40.
[17] Brick GW, Scott RD. The patellofemoral component of total knee arthroplasty. Clin Orthop Relat Res.1988 Jun;(231):163-178.
[18] Grelsamer RP, Weinstein CH. Applied biomechanics of the patella. Clin Orthop Relat Res, 2001, (389): 9-14.
[19] Barrack RL, Burak C. Patella in total knee arthroplasty. Clin Orthop Relat Res, 2001, (389): 62-73.
[20] Redziniak DE, Diduch DR, Mihalko WM, et al. Patellar instability. Instr Course Lect, 2010, (59): 195-206.
[21] Conlan T, Garth WP Jr, Lemons JE. Evaluation of the medial soft-tissue restraints of the extensor mechanism of the knee. J Bone Joint Surg(Am), 1993, 75(5): 682-693.
[22] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. Instr Course Lect, 2004, (53):167-186.
[23] Park SJ, Jung YB, Jeong HJ, et al. Long-term results of primary total knee arthroplasty with and without patellar resurfacing. Acta Med Okayama, 2010, 64(5): 331-338.
[24] Motsis EK, Paschos N, Pakos EE, et al. Review article: Patellar instability after total knee arthroplasty. J Orthop Surg(Hong Kong), 2009, 17(3): 351-357.
[25] Cameron HU, Huffer B. Avascular necrosis of the patella following total knee replacement. Acta Orthop Belg, 1985, 51(5):805-810.
[26] Keating EM, Haas G, Meding JB. Patella fracture after post total knee replacements. Clin Orthop Relat Res, 2003, (416): 93-97.
[27] Swan JD, Stoney JD, Lim K, et al. The need for patellar resurfacing in total knee arthroplasty: a literature review. ANZ J Surg, 2010, 80(4): 223-33.
[28] Merle-Vincent F, Couris CM, Schott AM, et al. Cross-sectional study of pain and disability at knee replacement surgery for osteoarthritis in 299 patients. Joint Bone Spine, 2007, 74(6): 612-616.
[29] Elson DW, Brenkel IJ. Predicting pain after total knee arthroplasty. J Arthroplasty, 2006, 21(7):1047-1053.
[30] Spencer SJ, Young D, Blyth MJ. Secondary resurfacing of the patella in total knee arthroplasty. Knee, 2010, 17(3): 187-190.
[31] Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop (Belle Mead NJ), 2004, 33(2): 85-92.
[32] Wittstein JR, O'Brien SD, Vinson EN, et al. MRI evaluation of anterior knee pain: predicting response to nonoperative treatment. Skeletal Radiol, 2009, 38(9): 895-901.
[33] Dale H, Hallan G, Hallan G, et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop, 2009, 80(6): 639-645.
[34] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[35] Dennis DA, Channer M. Retained distal femoral osteophyte. An infrequent cause of postoperative pain following total knee arthroplasty. J Arthroplasty, 1992, 7(2):193-195.
[36] Biedert RM, Sanchis-Alfonso V. Sources of anterior knee pain. Clin Sports Med, 2002, 21(3): 335-347.
[37] Burnett RS, Bourne RB. Indications for patellar resurfacing in total knee arthroplasty. J Bone Joint Surg(Am), 2003, 85(4): 728–745
[38]张启栋,郭万首,张倩,等.膝关节置换术中髌骨置换与非髌骨置换比较的Meta分析.中国矫形外科杂志, 2010, 18(1):17-21.
[39] Waters TS,Bentley G. Patellar resurfacing in total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg(Am).2003, 85(2): 212-217.
[40] Calvisi V, Camillieri G, Lupparelli S. Resurfacing versus nonresurfacing the patella in total knee arthroplasty: a critical appraisal of the available evidence. Arch Orthop Trauma Surg, 2009, 129(9): 1261-1270.
[41] Pakos EE, Ntzani EE, Trikalinos TA. Patellar resurfacing in total knee arthroplasty. A meta-analysis. J Bone Joint Surg(Am), 2005, 87(7): 1438-1445.
[42] Burnett RS, Boone JL, McCarthy KP,et al. A prospective randomized clinical trial of patellar resurfacing and nonresurfacing in bilateral TKA. Clin Orthop Relat Res, 2007, (464): 65-72.
[43]李连华,孙天胜,王静,等.人工全膝关节置换术髌骨置换有效性的系统评价.中国循证医学杂志, 2009, 9(10): 1060-1066.
[44] Gildone A, Manfredini M, Biscione R, et al. Patella resurfacing inposterior stabilised total knee arthroplasty: a follow-up study in 56patients. Acta Orthop Belg, 2005, 71(4): 445-451.
[45] He JY, Jiang LS, Dai LY. Is patellar resurfacing superior than nonresurfacing in total knee arthroplasty? A meta-analysis of randomized trials. Knee, 2011, 18(3): 137-144.
[46] Davidson PA,Rivenburgh D.Focal anatomic patellofemoral inlay resurfacing: theoretic basis, surgical technique, and casereports. Orthop Clin North AM, 2008, 39(3): 337-346.
[47] Tunay S, Ozkan H, K se O, et al.Total knee arthroplasty in a patient with neglected congenital patellar dislocation. Orthropaedic, 2009, 32(10): 818-822.
[48] Aanderson JA,Baldini A,Sculco TP. Patellofemoral function after total knee arthroplasty: a comparison of 2 posterior-stabilized designs.J Knee Surg, 2008, 21(2): 91-96.
[49]翟生,凯塞尔江,武忠炎.全膝关节置换过程中是否行髌骨置换的系统评价.中国组织工程研究与临床康复, 2009, 13(13):2547-2552.
[50] Campbell DG, Duncan WW, Ashworth M, et al. Patellar resurfacing in total knee replacement: a ten-year randomised prospective trial. J Bone Joint Surg Br.2006 Jun;88(6):734-9.
[51]刘帆,吕厚山,闵志松.全膝人工关节置换术中髌骨置换对股四头肌肌力的影响.中华医学杂志, 2008, 88(12): 809-811.
[52] Bellemans J. Restoring the joint line in revision TKA: does it matter? Knee, 2004 Feb;11(1):3-5. Review.
[53] Chonko DJ,Lombardi AV JR, Berend KR. Patella baja and total knee arthroplasty (TKA): etiology, diagnosis, and management. Surg Technol Int, 2004, (12): 231-238.
[54] Fl?ren M, Davis J, Peterson MG, ET AL. A mini-midvastus capsular approach with patellar displacement decreases the prevalence of patella baja. J Arthroplasty, 2007, 22(6 Suppl 2): 51-57.
[55] Ikejiani CE, Leighton R, Petrie DP. Comparison of patellar resurfacing versus nonresurfacing in total knee arthroplasty. Can J Surg, 2000, 43(1): 35-38.
[56] Myles CM, Rowe PJ, Nutton RW, et al. The effect of patella resurfacing in total knee arthroplasty on functional range of movement measured by flexible electrogoniometry. Clin Biomech (Bristol, Avon), 2006, 21(7): 733-739.
[57]金丽颖.髌骨对膝关节运动影响的生物力学分析.山东体育学院学报, 2008, 24(2): 60-61.
[58] Insall JN, Ranawat CS, Aglietti P, et al. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg(Am),1976, 58(6): 754-765.
[59] Insall JN, Dorr LD, Scott RD, et al. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res, 1989, (248):13-14.
[60] Bellamy N. Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum, 1989, 18(4Suppl2):14-17.
[61] Li S, Chen Y, Su W, et al. Systematic review of patellar resurfacing in total knee arthroplasty. Int Orthop, 2011, 35(3): 305-316.
[62] Burnett RS, Boone JL, Rosenzweig SD, et al. Patellar resurfacing compared with nonresurfacing in total knee arthroplasty. A concise follow-up of a randomized trial. J Bone Joint Surg(Am), 2009, 91(11): 2562-2567.
[1] MemtsoudisSG, GonzálezDella Valle A, BesculidesMC, et al. In hospital complications andmortality ofunilateral, bilateral,and revision TKA: based on an estimate of4,159,661discharges. Clin OrthopRelatRes, 2008, 466(11):2617-2627.
[2] ParviziJ, Ghanem E, SharkeyP, et al. Diagnosis ofinfected total knee: findings ofa multicenterdatabase. Clin OrthopRelatRes, 2008, 466(11): 2628-2633.
[3] Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am, 1975, 6(4): 991-1003.
[4] Schmalzried TP, Amstutz HC, Au MK, et al. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res, 1992, (280): 200-207.
[5] Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg(Am), 1996 , 78(4): 512-523.
[6] Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly, 2005, 135(17-18): 243-251.
[7] Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retros- pective review of 6489 total knee replacements. Clin Orthop Relat Res, 2001, (392):15-23.
[8] Vince K, Chivas D, Droll KP. Wound Complications after Total Knee Arthropla- sty. J Arthroplasty, 2007, 22(4Suppl1): 39-44.
[9] Hofman AA, Kane KR, Tkach TK, et al. Treatment of infected total knee arthrop- lasty using an articulating spacer. Clin Orthop, 1995, (321): 45-54.
[10] Garvin KL, Hanssen AD. Infection after total hip arthroplasty, past, present, and future. J Bone Joint Surg(Am), 1995, (77):1576-1588.
[11] Urban JA, garunKL. Infection aftertolal hip arthroplasty. Curr Opin Orthop, 2003, (45): 68-71.
[12] Greidanus NV, Masri BA, Garbuz DS, et al. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg(Am), 2007, 89(7): 1409-1416.
[13] Spangeh MJ, Masri BA, O’Connell J X, et al. Prospective analysis of preoperative and in traoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg(Am), 1999, 8l(5): 672-683.
[14] Trampuz A, Steinrücken J, Clauss M, et al. New methods for the diagnosis of implant-associated infections. Borens O.Rev Med Suisse, 2010, 6(243): 731-734.
[15] Lonner JH, Desai P, Dicesare PE, et al. The reliability of analysis of intraoperative frozen sections for identirying active infection during revision hip or knee arthroplasty. J Bone Joint Surg(Am). 1996, 78(10): 1553-1158.
[16] Athanasou NA.Pandey R, deSteiger R, et al. Diagnosis of infection by frozen section during revision arthroplasty. J BoneJoint Surg(Br), 1995, 77(11): 28-33.
[17] Di Cesare P E, Chang E. Serum interleukin26 as a marker ofperip rosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg(Am), 2005 , 87 (9) : 1921-1927.
[18] Bongartz T, Halligan CS, Osmon DR, et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum, 2008, 59(12):1713-1720.
[19] Bolognesi MP, Marchant MH Jr, Viens NA, et al. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty, 2008, 23(6 Suppl 1): 92-98.
[20] American Academy of Orthopaedic Surgeons Patient Safety Committee (AAO SPSC), Evans RP. Surgical site infection prevention and control: an emerging paradigm. Bone Joint Surg(Am), 2009, 91(Suppl6): 2-9.
[21] Kuper M, Rosenstein A. Infection prevention in total knee and total hip arthroplastics. Am J Orthop(Belle Mead NJ), 2008, 37(1):2-5.
[22] Willemen D, Paul J, White SH, et al. Closed suction drainage following knee arthroplasty. Effectiveness and risks. Clin Orthop Relat Res, 1991, (264): 232-234.
[23] Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis, 1998, 27(5):1247-1254.
[24] Parvizi J, Ghanem E, Joshi A, et al. Does "excessive" anticoagulation predispose to periprosthetic infection?J Arthroplasty, 2007, (6 Suppl 2): 24-28.
[25] Chiu FY, Chen CM. Surgical débridement and parenteral antibiotics in infected revision total knee arthroplasty. Clin Orthop Relat Res, 2007, (461): 130-135.
[26] Burnett RS, Kelly MA, Hanssen AD, et al. Technique and timing of two-stage exchange for infection in TKA. Clin Orthop Relat Res, 2007, (464): 164-178.
[27] Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: Current status. Acta Orthop, 2006, 77(4): 628-637.
[28] Blom AW, Brown J, Taylor AM, et al. Infection after total knee arthroplasty. J Bone Joint Surg(Br), 2004, 86(5) :688-691.
[29]周勇刚,肖逸鹏,王岩,等.二期翻修在人工膝关节置换术后感染治疗中的作用.中华关节外科杂志(电子版), 2007, 1(4): 1-5.
[30] Hart WJ, Jones RS. Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy. J Bone Joint Surg Br, 2006, 88(8): 1011-5.